Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled study of KRP-KC318E in accommodative asthenopia
jRCT2080224737Phase 2Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of KRP-KC318E in asthenopia (3 arms), sponsored by Senju Pharmaceutical Co., Ltd. Primary endpoint: Primary efficacy and safety endpoints. Started Jun 2019; status: completed.
02
Drugs
KRP-KC318E
03
Conditions
asthenopia
Beyond the preview
Go deeper on jRCT2080224737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224737.